Stock Earnings

Question 1

Rhythm Pharmaceuticals Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Rhythm Pharmaceuticals Incの総資産は$392で、純lossは$-264です。

Question 2

RYTMの主要な財務比率は何ですか？

Accepted Answer

Rhythm Pharmaceuticals Incの流動比率は1.72、純利益率は-203.07、1株当たり売上高は$2.13です。

Question 3

Rhythm Pharmaceuticals Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Rhythm Pharmaceuticals Inc largest revenue segment is Therapeutics, at a revenue of 130,126,000 in the most earnings release.For geography, United States is the primary market for Rhythm Pharmaceuticals Inc, at a revenue of 96,108,000.

Question 4

Rhythm Pharmaceuticals Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Rhythm Pharmaceuticals Incの純lossは$-264です。

Question 5

Rhythm Pharmaceuticals Incに負債はありますか？

Accepted Answer

yes、Rhythm Pharmaceuticals Incの負債は227です。

Question 6

Rhythm Pharmaceuticals Incの発行済株式数は何株ですか？

Accepted Answer

Rhythm Pharmaceuticals Incの総発行済株式数は62.39株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	156	130	77	23	3	0
Revenue Growth (YoY)	23%	69%	235%	667%	--	--
Cost of Revenue	16	13	9	2	0	--
Gross Profit	139	116	68	21	2	--
Selling, General & Admin	158	144	117	92	68	46
Research & Development	158	237	134	108	104	90
Operating Expenses	316	382	252	200	172	136
Other Non Operating Income (Expenses)	1	2	0	0	100	--
Pretax Income	-183	-260	-184	-181	-69	-134
Income Tax Expense	0	0	0	--	0	--
Net Income	-188	-264	-184	-181	-69	-134
Net Income Growth	-53%	43%	2%	162%	-49%	-4%
Shares Outstanding (Diluted)	63.68	60.99	57.67	52.12	49.6	44.13
Shares Change (YoY)	4%	6%	11%	5%	12%	21%
EPS (Diluted)	-2.95	-4.33	-3.2	-3.47	-1.4	-3.04
EPS Growth	-55%	35%	-8%	148%	-54%	-21%
Free Cash Flow	-107	-113	-136	-173	-146	-122
Free Cash Flow Per Share	-1.68	-1.85	-2.35	-3.31	-2.94	-2.76
Gross Margin	89.1%	89.23%	88.31%	91.3%	66.66%	--
Operating Margin	-113.46%	-203.84%	-238.96%	-778.26%	-5,666.66%	0%
Profit Margin	-120.51%	-203.07%	-238.96%	-786.95%	-2,300%	0%
Free Cash Flow Margin	-68.58%	-86.92%	-176.62%	-752.17%	-4,866.66%	0%
EBITDA	-176	-264	-183	-178	-169	-136
EBITDA Margin	-112.82%	-203.07%	-237.66%	-773.91%	-5,633.33%	0%
D&A For EBITDA	1	1	1	1	1	0
EBIT	-177	-265	-184	-179	-170	-136
EBIT Margin	-113.46%	-203.84%	-238.96%	-778.26%	-5,666.66%	0%
Effective Tax Rate	0%	0%	0%	--	0%	--

Rhythm Pharmaceuticals Inc (RYTM) Price

RYTM Stock Price Chart

RYTM Income

Follow-Up Questions